Global Transdermal Contraceptive Patch Market Insights, Forecast to 2034
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Transdermal Contraceptive Patch Market Insights, Forecast to 2034
A transdermal contraceptive patch, often simply referred to as a contraceptive patch, is a birth control method that provides hormonal contraception through the skin. It is a convenient and reversible form of contraception for people who prefer not to take oral contraceptive pills or use other birth control methods.
How it WorksThe transdermal contraceptive patch is designed to release hormones into the body through the skin. It typically contains two synthetic hormonesestrogen and progestin.
Using a transdermal contraceptive patch typically involves the following steps
PlacementThe patch is a small, adhesive square or rectangle that is applied directly to the skin. It is usually placed on the buttocks, abdomen, upper torso, or outer arm. It should not be applied to the breasts or any area with cuts, irritation, or lotions.
Change ScheduleDepending on the specific brand and type of patch, it needs to be changed once a week for three weeks in a row, followed by a one-week patch-free period.
Cycle ContinuationAfter the patch-free week, a new cycle begins with the application of a fresh patch. This cycle continues as long as contraception is desired.
Global Transdermal Contraceptive Patch market is expected to reach to US$ million in 2024, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Transdermal Contraceptive Patch industry is evaluated to reach US$ million in 2029. The CAGR will be % during 2024 to 2029.
Globally, Transdermal Contraceptive Patch key manufacturers include Gedeon Richter, Mylan Pharmaceuticals, Twirla, Luye Pharma and AbbVie, etc. Gedeon Richter, Mylan Pharmaceuticals, Twirla are top 3 players and held % sales share in total in 2022.
When considering the consumption regions, % volume of Transdermal Contraceptive Patch were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029 and the sales share will be % in 2029. Moreover, China, plays a key role in the whole Transdermal Contraceptive Patch market and estimated to attract more attentions from industry insiders and investors.
Transdermal Contraceptive Patch can be divided into Seven Days Replacement and Three Days Replacement, etc. Seven Days Replacement is the mainstream product in the market, accounting for % sales share globally in 2022 and the proportion will be % in 2029.
Transdermal Contraceptive Patch is widely used in various fields, such as Online Sales and Offline Sales, etc. Online Sales provides greatest supports to the Transdermal Contraceptive Patch industry development. In 2022, global % sales of Transdermal Contraceptive Patch went into Online Sales filed and the proportion will reach to % in 2029.
Report Covers
This report presents an overview of global Transdermal Contraceptive Patch market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Transdermal Contraceptive Patch market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report
Gedeon Richter
Mylan Pharmaceuticals
Twirla
Luye Pharma
AbbVie
Segment by Type
Seven Days Replacement
Three Days Replacement
Online Sales
Offline Sales
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Transdermal Contraceptive Patch plant distribution, commercial date of Transdermal Contraceptive Patch, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Transdermal Contraceptive Patch introduction, etc. Transdermal Contraceptive Patch Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports’s Conclusions of Transdermal Contraceptive Patch
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports
How it WorksThe transdermal contraceptive patch is designed to release hormones into the body through the skin. It typically contains two synthetic hormonesestrogen and progestin.
Using a transdermal contraceptive patch typically involves the following steps
PlacementThe patch is a small, adhesive square or rectangle that is applied directly to the skin. It is usually placed on the buttocks, abdomen, upper torso, or outer arm. It should not be applied to the breasts or any area with cuts, irritation, or lotions.
Change ScheduleDepending on the specific brand and type of patch, it needs to be changed once a week for three weeks in a row, followed by a one-week patch-free period.
Cycle ContinuationAfter the patch-free week, a new cycle begins with the application of a fresh patch. This cycle continues as long as contraception is desired.
Global Transdermal Contraceptive Patch market is expected to reach to US$ million in 2024, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Transdermal Contraceptive Patch industry is evaluated to reach US$ million in 2029. The CAGR will be % during 2024 to 2029.
Globally, Transdermal Contraceptive Patch key manufacturers include Gedeon Richter, Mylan Pharmaceuticals, Twirla, Luye Pharma and AbbVie, etc. Gedeon Richter, Mylan Pharmaceuticals, Twirla are top 3 players and held % sales share in total in 2022.
When considering the consumption regions, % volume of Transdermal Contraceptive Patch were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029 and the sales share will be % in 2029. Moreover, China, plays a key role in the whole Transdermal Contraceptive Patch market and estimated to attract more attentions from industry insiders and investors.
Transdermal Contraceptive Patch can be divided into Seven Days Replacement and Three Days Replacement, etc. Seven Days Replacement is the mainstream product in the market, accounting for % sales share globally in 2022 and the proportion will be % in 2029.
Transdermal Contraceptive Patch is widely used in various fields, such as Online Sales and Offline Sales, etc. Online Sales provides greatest supports to the Transdermal Contraceptive Patch industry development. In 2022, global % sales of Transdermal Contraceptive Patch went into Online Sales filed and the proportion will reach to % in 2029.
Report Covers
This report presents an overview of global Transdermal Contraceptive Patch market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Transdermal Contraceptive Patch market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Gedeon Richter
Mylan Pharmaceuticals
Twirla
Luye Pharma
AbbVie
Segment by Type
Seven Days Replacement
Three Days Replacement
Segment by Application
Online Sales
Offline Sales
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Transdermal Contraceptive Patch plant distribution, commercial date of Transdermal Contraceptive Patch, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Transdermal Contraceptive Patch introduction, etc. Transdermal Contraceptive Patch Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports’s Conclusions of Transdermal Contraceptive Patch
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices